FDA Takes “Fresh Look” At ORA Reorg, Eyes Outsourcing Some Agency Posts
FDA's decision to cancel the planned closure of seven field labs does not signal the end of efforts to reorganize the Office of Regulatory Affairs
FDA's decision to cancel the planned closure of seven field labs does not signal the end of efforts to reorganize the Office of Regulatory Affairs